Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
German drugmaker Bayer has agreed to buy Schiff Nutrition International for $1.1bn. The goal is to add a faster-growing vitamins business to Bayer's consumer-health unit. Bayer CEO Marijn Dekkers speaks to Bloomberg's Elliott Gotkine.
On Air Now
Max 250 characters
©2013 Bloomberg L.P. All Rights Reserved. Made in NYC